Perspective on the current state of the LRRK2 field
JM Taymans, M Fell, T Greenamyre, WD Hirst… - npj Parkinson's …, 2023 - nature.com
Almost 2 decades after linking LRRK2 to Parkinson's disease, a vibrant research field has
developed around the study of this gene and its protein product. Recent studies have begun …
developed around the study of this gene and its protein product. Recent studies have begun …
New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin
K Senkevich, U Rudakou, Z Gan-Or - Neuropharmacology, 2022 - Elsevier
Parkinson's disease (PD) is defined as a complex disorder with multifactorial pathogenesis,
yet a more accurate definition could be that PD is not a single entity, but rather a mixture of …
yet a more accurate definition could be that PD is not a single entity, but rather a mixture of …
LRRK2 phosphorylation status and kinase activity regulate (macro) autophagy in a Rab8a/Rab10-dependent manner
E Kania, JS Long, DG McEwan, K Welkenhuyzen… - Cell Death & …, 2023 - nature.com
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common genetic
cause of Parkinson's disease (PD), with growing importance also for Crohn's disease and …
cause of Parkinson's disease (PD), with growing importance also for Crohn's disease and …
LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease
SYY Pang, RCN Lo, PWL Ho, HF Liu… - Translational …, 2022 - Springer
Mutations in leucine-rich repeat kinase 2 (LRRK2) and glucocerebrosidase (GBA) represent
two most common genetic causes of Parkinson's disease (PD). Both genes are important in …
two most common genetic causes of Parkinson's disease (PD). Both genes are important in …
The emerging roles of autophagy in human diseases
Y Lei, DJ Klionsky - Biomedicines, 2021 - mdpi.com
Autophagy, a process of cellular self-digestion, delivers intracellular components including
superfluous and dysfunctional proteins and organelles to the lysosome for degradation and …
superfluous and dysfunctional proteins and organelles to the lysosome for degradation and …
The small GTPase Rit2 modulates LRRK2 kinase activity, is required for lysosomal function and protects against alpha-synuclein neuropathology
J Obergasteiger, AM Castonguay, S Pizzi… - npj Parkinson's …, 2023 - nature.com
In Parkinson's disease (PD) misfolded alpha-synuclein (aSyn) accumulates in the substantia
nigra, where dopaminergic neurons are progressively lost. The mechanisms underlying …
nigra, where dopaminergic neurons are progressively lost. The mechanisms underlying …
[HTML][HTML] Precise control of mitophagy through ubiquitin proteasome system and deubiquitin proteases and their dysfunction in Parkinson's disease
GH Park, JH Park, KC Chung - BMB reports, 2021 - ncbi.nlm.nih.gov
Parkinson's disease (PD) is one of the most common neurodegenerative diseases in the
elderly population and is caused by the loss of dopaminergic neurons. PD has been …
elderly population and is caused by the loss of dopaminergic neurons. PD has been …
High-content phenotyping of Parkinson's disease patient stem cell-derived midbrain dopaminergic neurons using machine learning classification
A Vuidel, L Cousin, B Weykopf, S Haupt, Z Hanifehlou… - Stem Cell Reports, 2022 - cell.com
Combining multiple Parkinson's disease (PD) relevant cellular phenotypes might increase
the accuracy of midbrain dopaminergic neuron (mDAN) in vitro models. We differentiated …
the accuracy of midbrain dopaminergic neuron (mDAN) in vitro models. We differentiated …
Mitochondrial quality control strategies: potential therapeutic targets for neurodegenerative diseases?
Many lines of evidence have indicated the therapeutic potential of rescuing mitochondrial
integrity by targeting specific mitochondrial quality control pathways in neurodegenerative …
integrity by targeting specific mitochondrial quality control pathways in neurodegenerative …
[HTML][HTML] Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo
F Albanese, D Mercatelli, L Finetti, G Lamonaca… - Neurobiology of …, 2021 - Elsevier
Mutations in leucine-rich repeat kinase 2 (LRRK2) are associated with Parkinson's disease.
LRRK2 modulates the autophagy-lysosome pathway (ALP), a clearance process subserving …
LRRK2 modulates the autophagy-lysosome pathway (ALP), a clearance process subserving …